Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess the performance of the chocolate balloon.Survey results received for a cardiothoracic surgeon with 14 years of experience who has been using the chocolate balloon since 2015.The physician has used a total of 1008 chocolate balloons, with 224 of these being used in the past 12 months for dilatation of stenoses in the iliac arteries, femoral arteries, popliteal arteries, infra-popliteal arteries, and renal arteries.The respondent reports device related complications of arterial dissection or perforation, arteriovenous fistula, restenosis of treated artery, and surgical repair of vascular site which was all previously reported to medtronic.The respondent reports device related complications of hemorrhage or hematoma and infection (local or systemic) which was not previously reported to medtronic.The hemorrhage or hematoma, infection (local or systemic), surgical repair of the vascular access site, and intimal lesion events were considered to be not at all concerning.The arterial dissection or perforation, arteriovenous fistula, and restenosis of treated artery events were considered to be somewhat concerning.
|